Results 251 to 260 of about 265,496 (312)

Allogeneic Marrow Transplantation

Cancer Investigation, 1984
After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.
K M, Sullivan, R, Storb
openaire   +2 more sources

SEROLOGIC ALLOGENEIC CHIMERISM

Transplantation, 1997
At least some transplanted livers secrete soluble human leukocyte antigens (sHLA) of donor phenotype into the body fluids of recipients. The individuals in whom this phenomenon occurs are by definition serologic allogeneic chimeras. Because an allogeneic transplanted liver may induce tolerance to itself and other organs in animals of the donor strain ...
J C, McDonald, I, Adamashvili, G B, Zibari, D F, Aultman, M C, Mancini, R W, McMillan, F B, Gelder   +6 more
openaire   +2 more sources

Allogeneic islet transplantation

Expert Opinion on Biological Therapy, 2007
Significant progress has been made in the field of beta-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials have shown that islet transplantation can reproducibly lead to insulin independence when adequate islet numbers are implanted.
Simona, Marzorati, Antonello, Pileggi, Camillo, Ricordi   +2 more
openaire   +2 more sources

Allogeneic Stem Cell Transplantation

Transplantation Proceedings, 2005
Allogeneic stem cell transplantation (HSCT) requires the harvest of an adequate number of stem cells (SC) from a histocompatible donor and their infusion into a patient following a conditioning regimen. During the past 35 years, the role of HSCT has changed from an experimental procedure for terminally ill patients to a curative treatment.
BOSI, ALBERTO, BARTOLOZZI B, GUIDI S.
openaire   +3 more sources

Allogene Stammzelltransplantation

Onkologische Pflege, 2023
Menschen nach einer Stammzelltransplantation haben einen erhöhten Beratungsbedarf. Die thematischen Schwerpunkte erstrecken sich sowohl über medizinisch als auch persönlich orientierte Themen. Zudem kann der Beratungsbedarf altersabhängig variieren und auch die Menge der benötigten Informationen hängt von der Bewältigungsstrategie ab.
Aleksandra Trojan, Johannes Bösche
openaire   +1 more source

Allogeneic Diseases

1994
info:eu-repo/semantics ...
Florquin, Sandrine, Goldman, Michel
openaire   +1 more source

Allogene Knochenmarktransplantation

Onkologische Welt, 2019
Die US-amerikanische Food and Drug Administration (FDA) erließ eine Warnung vor Immuncheckpoint-Inhibitoren, wenn sie als Bridging-Therapie vor einer allogenen Knochenmarktransplantation eingesetzt werden. Grund waren Hinweise auf häufigere immunassoziierte Komplikationen nach der Übertragung.
openaire   +1 more source